Ronald J. Ellis Jr. - 06 Jun 2023 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Strategy Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
06 Jun 2023
Net transactions value
-$87,435
Form type
4
Filing time
07 Jun 2023, 21:20:41 UTC
Previous filing
28 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale $43,436 -1,114 -3.4% $38.99 32,071 06 Jun 2023 Direct F1
transaction PCRX Common Stock Sale $43,999 -1,162 -3.6% $37.86 30,909 07 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.